Press Releases

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

2015 Archives

Mar 12, 2015
-- Provides additional product updates --
Mar 11, 2015
Conference Call and Webcast scheduled for March 13, 2015, 8:30 a.m. ET
Feb 24, 2015
Product is the first approved monoclonal antibody to aid in the treatment of canine B-cell lymphoma
Feb 10, 2015
Provides additional details on AT-001 pivotal efficacy study, announces two technical section complete letters for safety, provides manufacturing update for AT-004, and announces completion of enrollment for AT-005's T-CHOMP study
Jan 5, 2015
Represents a Novel Approach to Treating B-cell Lymphoma in Dogs
 
print email rss